ESC 365 - Doctor Luigi Spadafora

Speaker illustration

Doctor Luigi Spadafora

Sapienza University of Rome, Latina (Italy)

Member of:

European Society of Cardiology

European Association of Preventive Cardiology

European Association of Percutaneous Cardiovascular Interventions

Heart Failure Association of the ESC

Presentations Articles

Benefits of physiology-guided complete revascularization of non-culprit lesions in elderly patients with myocardial infarction across the spectrum of GRACE score: insights from the FIRE trial.

Event: ESC Congress 2025

Topic: Intracoronary Flow and Pressure Measurements

Session: Coronary physiology and microcirculatory assessment

SGLT2 inhibitors improve cardiovascular clinical outcomes in patients undergoing anthracycline chemotherapy: a systematic review and meta-analysis of 13,333 patients.

Event: ESC Congress 2025

Topic: Cardiotoxicity of Drugs and Other Therapies

Session: SGLT2 inhibitors in heart failure: prevention and treatment

One-year clinical outcomes of NSTEMI patients according to left ventricular ejection fraction: data from a large multicenter registry.

Event: ESC Congress 2025

Topic: Epidemiology, Prognosis, Outcome

Session: Insights into incident heart failure

Features and predictors of 1-year outcomes in cancer patients discharged after acute coronary syndrome: insights from a multicenter registry.

Event: ESC Cardio-Oncology 2025

Topic: Diagnosis and Management of Cardiovascular Disease in Patients with Cancer

Session: Decoding cardiac biomarkers and coronary interventions in patients with cancer

Higher systolic pulmonary artery pressure as a predictor of anthracycline-induced cardiac dysfunction in patients with hematologic malignancies.

Event: ESC Cardio-Oncology 2025

Topic: Stratification, Prevention and Monitoring

Session: Poster session (2)

Impact of different types of hematologic disorders on anthracycline-induced cardiotoxicity: a retrospective analysis.

Event: ESC Cardio-Oncology 2025

Topic: Stratification, Prevention and Monitoring

Session: Poster session (1)

Clinical predictors of one-year mortality in STEMI patients across the spectrum of LVEF: insights from a large multicenter registry.

Event: Heart Failure 2025

Topic: Epidemiology, Prognosis, Outcome

Session: Valvular heart disease, LV and RV function and imaging

Regional disparities in STEMI management and outcomes in italy: an analysis of time-dependent reperfusion networks and in-hospital logistics

Event: ESC Preventive Cardiology 2025

Topic: Prevention

Session: Poster session (2)

Hemoglobin/creatinine ratio as long- term prognostic marker in acute coronary syndromes: a praise registry study.

Event: ESC Congress 2024

Topic: Biomarkers

Session: Risk factors, risk scores, and outcomes after acute coronary syndromes

ESC 365 is supported by

bristol-myers-squibb

Explore sponsored resources

novartis

Explore sponsored resources